Skip to main content
AEON
NYSE Life Sciences

AEON 10-Q: $2.5M Q3 Profit Is Non-Cash; Going Concern and $0.25 Delisting Rule Loom

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.141
Mkt Cap
$8.313M
52W Low
$0.127
52W High
$1.45
52W Position info
11% above low
Off High info
90% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

AEON is trading near its 52-week low of $0.127 (11% above the low) on light trading volume (0.1× avg).

Summary

AEON's Q3 profit is entirely a $7.0 million non-cash warrant mark; the operating loss was $4.5 million and cash funds operations only into Q2 2027, with the filing flagging substantial going-concern doubt and a $0.25 delisting threshold arriving July 1, 2027.


Key Events · Earnings and Guidance · AEON

  • Q3 Profit Is Non-Cash

    Q3 2026 net income of $2.465 million versus a $4.538 million loss a year earlier, driven by a $7.014 million non-cash gain on warrant fair-value remeasurement; the operating loss was $4.483 million.

  • Going Concern and Runway

    Cash and equivalents were $11.4 million at September 30, 2026, which excludes about $6.2 million of milestone-warrant proceeds received in Q4; together the company expects funding into Q2 2027, and management concluded there is substantial doubt about the ability to continue as a going concern.

  • Equity Below Listing Minimum

    Stockholders' equity was $2.386 million at September 30, 2026, below the $4.0 million minimum under NYSE American Section 1003(a)(ii); the company says the $6.2 million of Q4 warrant exercises lift equity above the threshold as of the filing date.

  • $0.25 Delisting Rule Ahead

    Under a NYSE American rule effective July 1, 2027, a closing price below $0.25 on any trading day triggers immediate suspension and delisting proceedings; the stock last reported at $0.159 on November 12, 2026.


Analysis · AEON · Life Sciences

The headline profit is an accounting artifact: Q3 net income of $2.465 million came from a $7.014 million non-cash gain on warrant remeasurement, while the operating loss was $4.483 million. The real story is survival math. Cash was $11.4 million at September 30, plus roughly $6.2 million of milestone-warrant proceeds received in Q4, which management says funds operations only into Q2 2027 — and the filing states substantial doubt about the company's ability to continue as a going concern. Equity of $2.386 million sits below NYSE American's $4.0 million minimum, and a new exchange rule taking effect July 1, 2027 will suspend and delist any stock closing below $0.25 on any trading day. With the stock at $0.141, a reverse split is the only lever, and the December 15, 2026 special meeting seeks authority for 1-for-2 through 1-for-100 — though the February 2025 1-for-72 split caps any near-term ratio at roughly 1-for-2.78.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AEON was trading at $0.14 on NYSE in the Life Sciences sector, with a market capitalization of approximately $8.3M. The 52-week trading range was $0.13 to $1.45. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AEON - Latest Insights

AEON
Nov 16, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.141
Real-time Price: $0.141 info
Change: $0 (0%) info
Market Cap: $8.313M info
AEON
Nov 10, 2026, 12:12 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.172
Real-time Price: $0.141 info
Change: -$0.031 (-18%) info
Market Cap: $8.313M info
AEON
Nov 03, 2026, 8:43 AM EST
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.2797
Real-time Price: $0.141 info
Change: -$0.1387 (-50%) info
Market Cap: $8.313M info
AEON
Nov 03, 2026, 8:42 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2797
Real-time Price: $0.141 info
Change: -$0.1387 (-50%) info
Market Cap: $8.313M info